Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
Abstract
Management of high-grade gliomas remains a complex challenge. Standard of care consists of microsurgical resection, chemotherapy and radiation, but despite these aggressive multimodality therapies the overall prognosis remains poor. A major focus of ongoing translational research studies is to develop novel therapeutic strategies that can maximize tumor cell eradication while minimizing collateral side effects. Particularly, biological...
Paper Details
Title
Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
Published Date
Nov 1, 2019
Journal
Volume
8
Issue
3
Pages
CNS38 - CNS38
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History